BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32664788)

  • 1. Severe aortic valve regurgitation requiring mechanical aortic valve replacement following Impella device implantation.
    Vila P; de Vere F; Simon A; Walker C
    Perfusion; 2021 Apr; 36(3):311-314. PubMed ID: 32664788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prosthetic valve replacement for aortic leaflet tear secondary to Impella device placement.
    Nishimura K; Iida M; Shimokawa T
    J Artif Organs; 2020 Dec; 23(4):383-387. PubMed ID: 32632507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiogenic Shock Complicating Transcatheter Aortic Valve Replacement Due to Severe Para-Valvular Regurgitation.
    Alraies MC; Soud M; Pacha HM; Waksman R; Ben-Dor I
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):393-395. PubMed ID: 29146552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device.
    Oishi H; Kondo T; Fujimoto K; Mutsuga M; Morimoto R; Hirano KI; Sawamura A; Kazama S; Kimura Y; Shibata N; Kato H; Arao Y; Kuwayama T; Yamaguchi S; Hiraiwa H; Okumura T; Usui A; Murohara T
    J Artif Organs; 2020 Dec; 23(4):378-382. PubMed ID: 32562105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergent valve-in-valve transcatheter aortic valve replacement in patient with acute aortic regurgitation and cardiogenic shock with preoperative extracorporeal membrane oxygenator: A case report and review of the literature.
    Iantorno M; Ben-Dor I; Rogers T; Gajanana D; Attaran S; Buchanan KD; Satler LF; Shults CC; Thourani VH; Waksman R
    Cardiovasc Revasc Med; 2018 Dec; 19(8S):68-70. PubMed ID: 30455139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of severe aortic regurgitation in a patient with cardiogenic shock using a percutaneous left ventricular assist device and transcatheter occlusion of the failed aortic valve homograft as a bridge to surgical valve replacement.
    Pollak P; Lim DS; Kern J
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E141-5. PubMed ID: 23674479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion of an Abiomed Impella® left ventricular assist device following bioprosthetic aortic valve placement.
    Thomas MP; Altman A; Magovern GJ; Moraca RJ
    J Card Surg; 2013 Jul; 28(4):469-71. PubMed ID: 23675749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Almalla M; Kersten A; Altiok E; Marx N; Schröder JW
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):357-362. PubMed ID: 31268621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Impella 5.0 Prior to Transcatheter Aortic Valve Replacement in a Patient with Severe Aortic Stenosis and Cardiogenic Shock.
    Johnson DW; ErwinIII JP
    J Heart Valve Dis; 2017 Jul; 26(4):485-487. PubMed ID: 29302950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic valve injury and complete atrioventricular block related to Impella device.
    Inaba Y; Iida Y; Kozai Y; Sakamoto Y
    Gen Thorac Cardiovasc Surg; 2021 May; 69(5):882-884. PubMed ID: 33400204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bail-Out Use of Impella CP as a Bridge to TAVI in a Cardiogenic Shock Patient: The "Pump-Rewiring" Technique.
    Burzotta F; Nerla R; Trani C
    J Invasive Cardiol; 2016 Jan; 28(1):E1-5. PubMed ID: 26716594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery.
    Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I
    J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment With Impella Increases the Risk of De Novo Aortic Insufficiency Post Left Ventricular Assist Device Implant.
    Rao SD; Johnson B; Olia SE; Wald J; Medina V; Rame JE; Mazurek JA; Goldberg LR; Atluri P; Bermudez C; Acker M; Birati EY
    J Card Fail; 2020 Oct; 26(10):870-875. PubMed ID: 32681883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total percutaneous biventricular assist device implantation for fulminant myocarditis.
    Tominaga Y; Toda K; Miyagawa S; Yoshioka D; Kainuma S; Kawamura T; Kawamura A; Nakamoto K; Sakata Y; Sawa Y
    J Artif Organs; 2021 Jun; 24(2):254-257. PubMed ID: 32748246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency valve-in-valve transcatheter aortic valve replacement in a patient with degenerated bioprosthetic aortic stenosis and cardiogenic shock on veno-arterial extracorporeal membrane oxygenation.
    Summers MR; Mick S; Kapadia SR; Krishnaswamy A
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):592-596. PubMed ID: 28296034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency transcatheter aortic valve implantation in patients with severe aortic regurgitation and a left ventricle assist device: A case report and systematic review.
    van der Werf HW; Schurer RA; Vonck TE; Poelman JE; Klungel AA; Cernak V; van den Heuvel AF; van der Harst P
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):719-727. PubMed ID: 27245700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
    Ebert D; Mungard N; Mensch A; Homeister L; Willsch J; Ibe R; Baust H; Stiller M; Rebelo A; Ukkat J; Rigopoulos AG; Weber E; Bucher M; Noutsias M
    BMC Cardiovasc Disord; 2021 Nov; 21(1):528. PubMed ID: 34743690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rescue Use of ECPELLA for Sepsis-Induced Cardiogenic Shock Followed by Mitral Valve Replacement.
    Nakamura M; Imamura T; Oshima A; Sobajima M; Yokoyama S; Doi T; Fukahara K; Kinugawa K
    Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic valve replacement after iatrogenic injury related to an Impella device.
    Saitoh D; Kin H
    Asian Cardiovasc Thorac Ann; 2021 Jun; 29(5):420-423. PubMed ID: 33302693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.
    Bohné M; Chung DU; Tigges E; van der Schalk H; Waddell D; Schenker N; Willems S; Klingel K; Kivelitz D; Bahlmann E
    BMC Cardiovasc Disord; 2020 Dec; 20(1):519. PubMed ID: 33302874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.